Could a single infusion quiet the ringing? small trial tests brexanolone for tinnitus

NCT ID NCT05645432

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This small study tested a single 6-hour intravenous infusion of brexanolone in 10 adults with tinnitus. The main goal was to check safety and tolerability, while also measuring changes in tinnitus loudness. Results are limited due to the small size and lack of a placebo group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

brexanolone (allopregnanolone)

What this could lead to

If it works, this could point toward a new treatment to reduce tinnitus loudness.

What could go wrong

This is a very small, early-phase trial with only 10 participants and no placebo group. Results may not apply to everyone, and the drug may not show meaningful benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TINNITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tinnitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sage Investigational Site

    Atlanta, Georgia, 30331, United States

  • Sage Investigational Site

    Iowa City, Iowa, 52242, United States